Yuki Gosei Kogyo Co., Ltd. (JP:4531)
:4531
4531 Stock Chart & Stats
¥317.00
¥0.00(0.00%)
At close: 4:00 PM EST
¥317.00
¥0.00(0.00%)
Day’s Range― - ―
52-Week Range¥214.00 - ¥640.00
Previous CloseN/A
Volume43.40K
Average Volume (3M)39.67K
Market Cap
¥8.84B
Enterprise Value¥16.36B
Total Cash (Recent Filing)¥1.05B
Total Debt (Recent Filing)¥9.06B
Price to Earnings (P/E)23.5
Beta0.99
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.97%
Share Statistics
EPS (TTM)3.41
Shares Outstanding21,974,000
10 Day Avg. Volume32,460
30 Day Avg. Volume39,673
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)0.44
Price to Sales (P/S)0.38
P/FCF Ratio-4.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthMulti-year revenue expansion to ~¥15.1B indicates durable demand across pharmaceuticals, agriculture and industrial customers. Steady top-line growth supports scale advantages, customer relationships and recurring sales that underpin long-term product development and margin recovery.
Improving ProfitabilityThe shift from loss to positive net margins and stronger operating profit signals structural improvement in cost management and pricing power. Sustained profitability gains increase internal cash generation potential, support reinvestment in R&D, and improve returns to shareholders over multiple years.
Balance Sheet StabilityA stronger equity base and moderate leverage provide financial flexibility to fund capex, sustain supply agreements, and weather cyclical pressures. The capital buffer supports strategic partnerships and investment in specialty-chemical capabilities without immediate refinancing stress.
Bears Say
Negative Free Cash FlowPersistent negative free cash flow despite improved operating cash in 2025 (~¥2.14B) indicates heavy investment or working-capital strain. Continued FCF deficits increase reliance on the balance sheet, limit organic funding for growth, and raise execution risk over the medium term.
Margin Pressure & VolatilityEroding gross margins point to exposure to input-cost swings or limited pricing pass-through. Margin volatility undermines earnings predictability, constrains cash available for R&D or dividends, and makes capital allocation decisions harder during commodity or supply-chain shifts.
Rising DebtAn increase in absolute debt to ~¥8.5B raises leverage risk, especially alongside negative FCF. Higher debt can increase interest burden and reduce flexibility for opportunistic investments or weathering demand slowdowns, constraining strategic options over the coming quarters.
Yuki Gosei Kogyo Co., Ltd. News
4531 FAQ
What was Yuki Gosei Kogyo Co., Ltd.’s price range in the past 12 months?
Yuki Gosei Kogyo Co., Ltd. lowest stock price was ¥214.00 and its highest was ¥640.00 in the past 12 months.
What is Yuki Gosei Kogyo Co., Ltd.’s market cap?
Yuki Gosei Kogyo Co., Ltd.’s market cap is ¥8.84B.
When is Yuki Gosei Kogyo Co., Ltd.’s upcoming earnings report date?
Yuki Gosei Kogyo Co., Ltd.’s upcoming earnings report date is May 18, 2026 which is in 50 days.
How were Yuki Gosei Kogyo Co., Ltd.’s earnings last quarter?
Yuki Gosei Kogyo Co., Ltd. released its earnings results on Jan 30, 2026. The company reported ¥3.41 earnings per share for the quarter, beating the consensus estimate of N/A by ¥3.41.
Is Yuki Gosei Kogyo Co., Ltd. overvalued?
According to Wall Street analysts Yuki Gosei Kogyo Co., Ltd.’s price is currently Overvalued.
Does Yuki Gosei Kogyo Co., Ltd. pay dividends?
Yuki Gosei Kogyo Co., Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of 2.97%. See more information on Yuki Gosei Kogyo Co., Ltd. dividends here
What is Yuki Gosei Kogyo Co., Ltd.’s EPS estimate?
Yuki Gosei Kogyo Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Yuki Gosei Kogyo Co., Ltd. have?
Yuki Gosei Kogyo Co., Ltd. has 21,974,000 shares outstanding.
What happened to Yuki Gosei Kogyo Co., Ltd.’s price movement after its last earnings report?
Yuki Gosei Kogyo Co., Ltd. reported an EPS of ¥3.41 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -14.693%.
Which hedge fund is a major shareholder of Yuki Gosei Kogyo Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4531
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Yuki Gosei Kogyo Co., Ltd.
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.
Technical Analysis
NANKAI CHEMICAL COMPANY LIMITED
―
Nippon Soda Co., Ltd.
―
Toho Acetylene Co., Ltd.
―
Daito Chemix Corporation
―
Toyo Gosei Co., Ltd.
―